Updated: 19 July 2024

Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug

19 July 2024

Must Read

The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.

Source link

World Matchplay: Luke Humphries pulls through to reach semi-finals

7 Hidden Benefits of a High Savings Rate (Beyond Building Wealth Fast)

- Advertisement -

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here

- Advertisement -

Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug

LEAVE A REPLY Cancel reply

The Best Items From the Shopbop Sale January 2026

There’s a Years Long Lag in AI Hype Cycle, Ex OpenAI Researcher Says

Some U.Va. Board Members Asked to Resign as Gov. Abigail Spanberger Takes Power

USDT0 Becomes the Largest and Fastest-Growing Cross-Chain Liquidity Network, $63 Billion Moved in One Year

January scams spike as criminals target tax data and personal information

More Articles Like This

Category

Links

Stay connected

Mail us : thetimes365@thetimes365.com

Newsletter Signup